Healthcare Services

Rising Cancer Prevalence Driving Expansion in the Targeted Therapy Market

April 28, 2026April 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Targeted Therapy Market During 2026–2030?

The targeted therapy market has experienced substantial expansion in recent years. This market is projected to grow from $109.99 billion in 2025 to $118.16 billion by 2026, achieving a compound annual growth rate (CAGR) of 7.4%. Historically, this expansion is attributed to several factors, including the increasing global incidence of cancer, the expansion of oncology research funding, the growing adoption of monoclonal antibodies, advancements in molecular biology research, and the rising approval rate of targeted cancer drugs.

The targeted therapy market is anticipated to experience robust expansion over the coming years. By 2030, its size is projected to reach $158.2 billion, achieving a compound annual growth rate (CAGR) of 7.6%. This growth during the forecast period stems from factors such as increased investment in personalized medicine, the expanding application of AI-driven drug discovery, broader adoption of precision diagnostics, a growing need for less harmful cancer treatments, and heightened clinical trial activity in the field of oncology. Key trends anticipated for this period encompass the accelerated development of precision oncology drugs, increased acceptance of biomarker-guided treatment selection, the broadening of combination targeted therapies, the wider implementation of companion diagnostics, and a heightened emphasis on designing drugs specific to tumors.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

Which Key Factors Are Driving The Targeted Therapy Market Growth?

The rising incidence of cancer is anticipated to fuel the expansion of the targeted therapy market in the future. Cancer refers to medical conditions characterized by abnormal cells that spread into nearby tissues and multiply without control. This therapy works by interrupting the signals that promote cancer cell proliferation or by prompting these cells to undergo programmed cell death. It utilizes drugs to precisely pinpoint genes and proteins vital for the sustenance and proliferation of cancerous cells, thereby boosting its demand. As an illustration, the American Cancer Society, a US-based nonprofit cancer advocacy organization, reported in January 2024 that cancer cases rose to 2,001,140, up from 1,958,310 in 2023, indicating a 2.19% increase. Consequently, the growing occurrence of cancer will stimulate the growth of the targeted therapy market.

How Is The Targeted Therapy Market Organized By Segment Classification?

The targeted therapy market covered in this report is segmented –

1) By Type: Small Molecule Medicines, Monoclonal Antibodies

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

Subsegments:

1) By Small Molecule Medicines: Tyrosine Kinase Inhibitors (TKIs), Proteasome Inhibitors, Phosphatidylinositol 3-Kinase (PI3K) Inhibitors, Other Small Molecule Therapies

2) By Monoclonal Antibodies: Immune Checkpoint Inhibitors, Antibody-Drug Conjugates (ADCs), Cytokine Blockers, Other Monoclonal Antibodies

Which Trends Are Guiding The Direction Of The Targeted Therapy Market?

Leading companies in the targeted therapy market are increasingly focusing on strategic partnerships to provide reliable services to their customers. A strategic partnership involves an arrangement between two or more companies or organizations that assists each other or works collaboratively to achieve their respective goals. For instance, in September 2023, Shine Technologies, a US-based pharmaceutical industry company producing radioactive isotopes for medical applications, collaborated with Curadh MTR Inc., which is dedicated to improving and accelerating the development of molecularly targeted radiation therapies for solid tumors. This strategic alliance aims to harness the potential of radioisotopes to accurately target and eliminate cancer cells, offering new hope to patients and redefining the future of cancer treatment.

Who Are The Industry Participants Involved In The Targeted Therapy Market?

Major companies operating in the targeted therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol Myers Squibb, AstraZeneca, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Genmab A/S, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, Agilent Technologies Inc., Illumina Inc., Incyte Corporation, Sysmex Corporation, Exact Sciences Corporation, Seagen Inc., Exelixis Inc., Seattle Genetics Inc., Genentech Inc., Daiichi Sankyo Company Limited

Get The Full Targeted Therapy Market Report:

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Which Region Accounts For The Largest Portion Of The Targeted Therapy Market?

North America was the largest region in the targeted therapy market in 2025. The regions covered in the targeted therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Targeted Therapy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Browse Through More Reports Similar to the Global Targeted Therapy Market 2026, By The Business Research Company

Music Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/music-therapy-global-market-report

Neoantigen Targeted Therapies Market Report

https://www.thebusinessresearchcompany.com/report/neoantigen-targeted-therapies-global-market-report

Addictions Therapeutics Market Report

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795